Clearstead Advisors’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
Other funds holding NAGE
SW
TCM
Clearstead Advisors's NAGE Position: Q2 2026 in Review
Clearstead Advisors opened a new position in Niagen Bioscience (NAGE) in Q2 2026: 4 shares worth $14. The stake represents ﹤0.01% of the portfolio and ranks #3608 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in NAGE as recently as Q4 2025.
Clearstead Advisors first reported a position in NAGE in Q2 2025 and has held it in 4 quarters since. The position peaked at $7K in Q3 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.
- Clearstead Advisors held 4 shares of Niagen Bioscience worth $14 as of Q2 2026.
- Niagen Bioscience was a new Clearstead Advisors position in Q2 2026.
- Niagen Bioscience made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3608 holding.
- Clearstead Advisors first reported a position in Niagen Bioscience in Q2 2025 and has held it in 4 quarters since.
- Clearstead Advisors's Niagen Bioscience position peaked at $7K in Q3 2025.
- 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.